A recent study showed that inhibition of caspase-1 reduced IL-1β expression to baseline post retinal ischemia injury, while inhibition of caspase-8 further down-regulated the level of IL-1β, suggesting that IL levels could be regulated by both NLRP3-dependent and other pathways22. The gene discussed is CASP1; the disease is retinal ischemia.